Literature DB >> 19356579

Association of plaque composition and vessel remodeling in atherosclerotic renal artery stenosis: a comparison with coronary artery disease.

Tetsuro Kataoka1, Verghese Mathew, Ronen Rubinshtein, Charanjit S Rihal, Ryan Lennon, Lilach O Lerman, Amir Lerman.   

Abstract

OBJECTIVES: The current study was designed to investigate the relationship between renal arterial structure and vessel remodeling in patients with atherosclerotic renal artery stenosis (RAS), compared with that seen in coronary artery disease (CAD).
BACKGROUND: The nature and the tissue characterization of atherosclerotic RAS lesions have not been fully explored.
METHODS: Gray scale and virtual histology (VH) intravascular ultrasound imaging was used to assess 23 lesions in 14 consecutive RAS patients and 20 left main trunk lesions in age-matched CAD patients. Analysis included assessment of vessel area and atherosclerotic plaque area of the main renal artery or left main trunk. Plaque was characterized as fibrous tissue, fibro-fatty tissue, necrotic core, and dense calcium. Remodeling was assessed by means of the remodeling index (RI).
RESULTS: Positive remodeling (defined as RI > or =1.05) was present in 15 RAS and 9 CAD lesions, whereas intermediate/negative remodeling (RI <1.05) was present in 8 RAS and 11 CAD lesions. VH showed that the fibrous tissue was the most prominent plaque composition, followed by fibro-fatty, necrotic core, and dense calcium in both vascular beds. Greater vascular adaptive enlargement was observed in slices with plaque burden < or =40% compared with plaque burden >40% (p < 0.001 for all). Vessel area had a positive association with the area of all VH components (p < 0.001, for all). VH analysis shows that the most powerful determinant of adaptive vessel enlargement is dense calcium in RAS (p < 0.001), while that is necrotic core in CAD (p < 0.001). Necrotic core and dense calcium areas were greater in lesions with positive remodeling compared with intermediate/negative remodeling (p = 0.03, p = 0.03, respectively, in RAS; p = 0.005, p = 0.03, respectively, in CAD).
CONCLUSIONS: The current study demonstrates in humans that plaque composition as assessed by VH intravascular ultrasound has an important role of adaptive vessel enlargement, and it is related to renal artery remodeling in RAS in a pattern similar to CAD.

Entities:  

Mesh:

Year:  2009        PMID: 19356579      PMCID: PMC2941979          DOI: 10.1016/j.jcmg.2008.08.008

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN: 1876-7591


  28 in total

1.  Relationship between coronary artery remodeling and plaque vulnerability.

Authors:  Amanda M Varnava; Peter G Mills; Michael J Davies
Journal:  Circulation       Date:  2002-02-26       Impact factor: 29.690

2.  Coronary plaque classification with intravascular ultrasound radiofrequency data analysis.

Authors:  Anuja Nair; Barry D Kuban; E Murat Tuzcu; Paul Schoenhagen; Steven E Nissen; D Geoffrey Vince
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

3.  Morphological predictors of arterial remodeling in coronary atherosclerosis.

Authors:  Allen P Burke; Frank D Kolodgie; Andrew Farb; Deena Weber; Renu Virmani
Journal:  Circulation       Date:  2002-01-22       Impact factor: 29.690

4.  Clinical characteristics of renovascular hypertension.

Authors:  N Simon; S S Franklin; K H Bleifer; M H Maxwell
Journal:  JAMA       Date:  1972-05-29       Impact factor: 56.272

5.  Intravascular ultrasound-guided renal artery stenting.

Authors:  G Dangas; J R Laird; R Mehran; A J Lansky; G S Mintz; M B Leon
Journal:  J Endovasc Ther       Date:  2001-06       Impact factor: 3.487

6.  Incidental renal artery stenosis among a prospective cohort of hypertensive patients undergoing coronary angiography.

Authors:  Charanjit S Rihal; Stephen C Textor; Jerome F Breen; Michael A McKusick; Diane E Grill; John W Hallett; David R Holmes
Journal:  Mayo Clin Proc       Date:  2002-04       Impact factor: 7.616

7.  Contribution of increased minimal coronary resistance and attenuated vascular adaptive remodeling to myocardial ischemia in patients with systemic hypertension and ventricular hypertrophy.

Authors:  Tetsuro Kataoka; Shuichi Hamasaki; Sanemasa Ishida; Keishi Saihara; Hideki Okui; Tsuyoshi Fukudome; Takurou Shinsato; Etsuko Mizoguchi; Yuichi Ninomiya; Yutaka Otsuji; Shinichi Minagoe; Chuwa Tei
Journal:  Am J Cardiol       Date:  2004-08-15       Impact factor: 2.778

8.  Site-specific atherogenic gene expression correlates with subsequent variable lesion development in coronary and peripheral vasculature.

Authors:  Emile R Mohler; Lea Sarov-Blat; Yi Shi; Damir Hamamdzic; Andrew Zalewski; Colin Macphee; Raul Llano; Dan Pelchovitz; Sumeet K Mainigi; Hashim Osman; Troy Hallman; Klaudia Steplewski; Zachary Gertz; Min Min Lu; Robert L Wilensky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-14       Impact factor: 8.311

9.  Cholesterol-lowering treatment is associated with improvement in coronary vascular remodeling and endothelial function in patients with normal or mildly diseased coronary arteries.

Authors:  S Hamasaki; S T Higano; J A Suwaidi; R A Nishimura; K Miyauchi; D R Holmes; A Lerman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

10.  Compensatory enlargement of human atherosclerotic coronary arteries.

Authors:  S Glagov; E Weisenberg; C K Zarins; R Stankunavicius; G J Kolettis
Journal:  N Engl J Med       Date:  1987-05-28       Impact factor: 91.245

View more
  8 in total

1.  Plaque characteristics and arterial remodeling in coronary and peripheral arterial systems.

Authors:  Yoshiki Matsuo; Takuro Takumi; Verghese Mathew; Woo-Young Chung; Gregory W Barsness; Charanjit S Rihal; Rajiv Gulati; Eric T McCue; David R Holmes; Eric Eeckhout; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  Atherosclerosis       Date:  2012-05-31       Impact factor: 5.162

2.  Stenotic coexistence among coronary, renal and extracrainal arteries in Chinese patients.

Authors:  Yuqiang Fang; Xian Shu; Chenming Yang; Xukai Wang; Hongyong Wang; Chunjiang Fu; Weibin Shi; Ye Zhang; Qiao Chen; Li Yang; Chunyu Zeng
Journal:  J Thromb Thrombolysis       Date:  2012-11       Impact factor: 2.300

3.  The association between renal atherosclerotic plaque characteristics and renal function before and after renal artery intervention.

Authors:  Takuro Takumi; Verghese Mathew; Gregory W Barsness; Tetsuro Kataoka; Ronen Rubinshtein; Charanjit S Rihal; Rajiv Gulati; Eric Eeckhout; Ryan J Lennon; Lilach O Lerman; Amir Lerman
Journal:  Mayo Clin Proc       Date:  2011-12       Impact factor: 7.616

4.  Salvage from hemodialysis via percutaneous transluminal renal artery stenting for a jeopardized solitary functioning kidney: A case report.

Authors:  Tomomi Ueda; Hajime Aoki; Yusuke Ushio; Hirofumi Horikoshi; Tomoyuki Fukuzawa; Shingo Tanaka; Kazuhiko Yumoto
Journal:  J Cardiol Cases       Date:  2021-05-26

5.  Clinical Trial Report: The Presence and Rupture of Vulnerable Plaques in the Peripheral Circulation.

Authors:  Anand Prasad; Sotirios Tsimikas
Journal:  Curr Cardiovasc Imaging Rep       Date:  2010-06-08

6.  3D FIESTA pulse sequence for assessing renal artery stenosis: is it a reliable application in unenhanced magnetic resonance angiography?

Authors:  Caterina Gaudiano; Fiorenza Busato; Emiliana Ferramosca; Carlo Cecchelli; Beniamino Corcioni; Lucia Barbara De Sanctis; Antonio Santoro; Rita Golfieri
Journal:  Eur Radiol       Date:  2014-07-25       Impact factor: 5.315

7.  Fibro-Fatty Component is Important for the Long-Term Clinical Events in Patients Who Have Undergone Primary Percutaneous Coronary Intervention.

Authors:  Wan Ho Kim; Hyun Woong Park; Ki Hong Kim; In Girl Song; Dong Ju Yang; Chung Seop Lee; Young Hoon Seo; Taek Geun Kwon; Jang-Ho Bae
Journal:  Korean Circ J       Date:  2012-01-31       Impact factor: 3.243

Review 8.  Vascular Calcification: Is it rather a Stem/Progenitor Cells Driven Phenomenon?

Authors:  Aleksandra Leszczynska; J Mary Murphy
Journal:  Front Bioeng Biotechnol       Date:  2018-02-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.